2003•Clinical Lung CancerRequires access

Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients

Carlos Camps, Carmen Sarries, Bárbara Roig, José Javier Sánchez, Cristina Queralt, Eva Sancho, Natividad Martínez-Banaclocha, Miguel Tarón, Rafael Rosell

Open publisher page 54 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 54 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: ERCC1, Xeroderma pigmentosum, Nucleotide excision repair, Cisplatin, Gemcitabine, DNA repair, Lung cancer, Medicine

Back to paper search Browse research topics Original source

Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients — Research Paper | ScholarLens